Group 1 - The core viewpoint of the news is that Kangtong Medical has shown significant trading activity, with a notable increase in stock price and financing activities on January 12, indicating investor interest and market engagement [1] - On January 12, Kangtong Medical's stock price rose by 5.74%, with a trading volume of 286 million yuan, and a net financing purchase of 11.02 million yuan, reflecting strong market performance [1] - As of January 12, the total financing and securities lending balance for Kangtong Medical was 67.57 million yuan, which is 3.84% of its circulating market value, indicating a high level of financing activity compared to the past year [1] Group 2 - As of December 31, the number of shareholders for Kangtong Medical was 7,415, a decrease of 1.64% from the previous period, while the average circulating shares per person increased by 1.67% to 8,501 shares [2] - For the period from January to September 2025, Kangtong Medical reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, a significant decline of 150.92% [2] - Since its A-share listing, Kangtong Medical has distributed a total of 48.99 million yuan in dividends [3]
港通医疗1月12日获融资买入4211.24万元，融资余额6756.59万元